BK Technologies (BKTI) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Nov. 12, 2024
Document Information [Line Items]
Entity Central Index Key	0000002186
Entity Registrant Name	BK Technologies Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-32644
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	83-4064262
Entity Address, Address Line One	7100 Technology Drive
Entity Address, City or Town	West Melbourne
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32904
City Area Code	321
Local Phone Number	984-1414
Title of 12(b) Security	Common Stock, par value $0.60 per share
Trading Symbol	BKTI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		3,563,275

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 4,173	$ 3,456
Trade accounts receivable, net	9,345	7,902
Inventories, net	18,674	23,952
Prepaid expenses and other current assets	2,724	1,892
Total current assets	34,916	37,202
Property, plant and equipment, net	4,988	5,366
Operating lease right-of-use (ROU) assets	1,246	1,560
Investments	0	742
Deferred tax assets, net	4,116	4,116
Capitalized product development cost	751	0
Other assets	387	422
Total assets	46,404	49,408
Current liabilities:
Accounts payable	5,891	9,822
Accrued compensation and related taxes	2,084	1,302
Accrued warranty expense	906	722
Accrued other expenses and other current liabilities	1,128	363
Short-term operating lease liabilities	561	525
Credit facility	0	6,476
Notes payable-current portion	0	71
Deferred revenue	1,605	1,137
Total current liabilities	12,175	20,418
Long-term operating lease liabilities	861	1,260
Deferred revenue	7,381	6,419
Total liabilities	20,417	28,097
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $1.00 par value; 1,000,000 authorized shares; none issued or outstanding	0	0
Common stock; $0.60 par value; 10,000,000 authorized shares; 3,905,143 and 3,867,082 issued, and 3,563,063 and 3,577,002 outstanding shares as of September 30, 2024 and December 31, 2023, respectively	2,343	2,320
Additional paid-in capital	49,204	48,602
Accumulated deficit	(19,507)	(24,209)
Treasury stock, at cost, 342,080 and 290,080 shares as of September 30, 2024, and December 31, 2023, respectively	(6,053)	(5,402)
Total stockholders’ equity	25,987	21,311
Total liabilities and stockholders’ equity	$ 46,404	$ 49,408

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 1	$ 1
Preferred Stock, Shares Authorized (in shares)	1,000,000	1,000,000
Preferred Stock, Shares Issued (in shares)	0	0
Preferred Stock, Shares Outstanding (in shares)	0	0
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.6	$ 0.6
Common Stock, Shares Authorized (in shares)	10,000,000	10,000,000
Common Stock, Shares, Issued (in shares)	3,905,143	3,867,082
Common Stock, Shares, Outstanding (in shares)	3,563,063	3,577,002
Treasury Stock, Common, Shares (in shares)	342,080	290,080

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Sales, net	$ 20,179	$ 20,069	$ 58,664	$ 57,786
Expenses
Cost of products	12,343	13,663	36,993	41,282
Selling, general and administrative	5,225	5,812	16,052	17,681
Total operating expenses	17,568	19,475	53,045	58,963
Operating income (loss)	2,611	594	5,619	(1,177)
Other (expense) income:
Net interest expense	(1)	(131)	(281)	(429)
Gain on disposal of property, plant and equipment	0	0	2	0
Loss on investments	0	(342)	(91)	(831)
Other expense	(6)	(31)	(59)	(83)
Total other (expense), net	(7)	(504)	(429)	(1,343)
Income (loss) before income taxes	2,604	90	5,190	(2,520)
Provision for income tax (expense)	(247)	0	(488)	0
Net income (loss)	$ 2,357	$ 90	$ 4,702	$ (2,520)
Net income (loss) per share-basic: (in dollars per share)	$ 0.67	$ 0.03	$ 1.33	$ (0.74)
Net income (loss) per share-diluted: (in dollars per share)	$ 0.63	$ 0.03	$ 1.3	$ (0.74)
Weighted average shares outstanding-basic (in shares)	3,539,841	3,411,813	3,536,100	3,404,395
Weighted average shares outstanding-diluted (in shares)	3,751,073	3,445,022	3,623,241	3,404,395

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income (loss)	$ 4,702	$ (2,520)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Inventories allowances	27	(61)
Allowance for credit losses on accounts receivable	122	0
Amortization of deferred financing costs and other assets	75	113
Depreciation and amortization	1,251	1,218
Gain on sale of equipment	(2)	0
Loss on investments	91	831
Changes in operating assets and liabilities:
Trade accounts receivable	(1,565)	1,506
Inventories	5,251	593
Prepaid expenses and other current assets	(832)	(385)
Capitalized product development cost	(751)	0
Other assets	35	(277)
ROU assets and lease liabilities	(49)	(38)
Accounts payable	(3,931)	(1,135)
Accrued compensation and related taxes	782	412
Accrued warranty expense	184	145
Deferred revenue	1,430	2,660
Accrued other expenses and other current liabilities	765	(58)
Net cash provided by operating activities	8,210	3,940
Investing activities
Purchases of property, plant, and equipment	(871)	(1,835)
Net cash used in investing activities	(871)	(1,835)
Financing activities
Proceeds from common stock issuance	0	63
Proceeds from the credit facility and notes payable	46,359	58,896
Repayment of the credit facility and notes payable	(52,981)	(58,916)
Net cash (used in) provided by financing activities	(6,622)	43
Net change in cash and cash equivalents	717	2,148
Cash and cash equivalents, beginning of period	3,456	1,918
Cash and cash equivalents, end of period	4,173	4,066
Supplemental disclosure
Cash paid for interest	357	487
Non-cash financing activity
Common stock issued under restricted stock units	376	556
Share-Based Payment Arrangement, Option [Member]
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation expense	210	163
Restricted Stock Units (RSUs) [Member]
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation expense	$ 415	$ 773

Note 1 - Condensed Consolidated

Note 1 - Condensed Consolidated Financial Statements	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 1. Basis of Presentation The condensed consolidated balance sheet as of September 30, 2024 three nine September 30, 2024 2023 nine September 30, 2024 2023 December 31, 2023 These condensed consolidated financial statements have been prepared in accordance with the requirements of Article 8 X 10 10 December 31, 2023 March 14, 2024. three nine September 30, 2024 2023 not Principles of Consolidation The accounts of the Company and its subsidiaries have been included in the accompanying condensed consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates entities in which it has a controlling financial interest. When the Company does not 20% 50% not Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, trade accounts receivable, investments, accounts payable, accrued expenses, notes payable, credit facilities, and other liabilities. As of September 30, 2024 December 31, 2023 Effective September 14, 2022, 7, 820 not not On January 25, 2024, first 2024. Liquidity On November 22, 2022, one November 22, 2023, one 12 September 2024. October 30, 2024, 14 Management believes that cash and cash equivalents currently available, combined with anticipated cash to be generated from operations, and borrowing ability are sufficient to meet the Company’s working capital requirements in the foreseeable future. The Company generally relies on cash from operations, commercial debt, and equity offerings to the extent available, to satisfy its liquidity needs and to meet its payment obligations. The Company may Reverse Stock Split On March 23, 2023, one 1 five 5 April 4, 2023, The Company executed the Reverse Stock Split, which became effective at 5:00 April 21, 2023. Recent Accounting Pronouncements The Company does not not In November 2023, 2023 07 280 December 15, 2023, December 15, 2024.

Note 2 - Significant Events and

Note 2 - Significant Events and Transactions	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Significant Events and Transactions Disclosure [Text Block]	Note 2. Significant Events and Transactions On November 6, 2023, third three 30 November 6, 2023, Additionally, East West purchased a warrant (“Warrant”), with a five not 4 2 1933,

Note 3 - Allowance for Credit L

Note 3 - Allowance for Credit Losses	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Allowance for Credit Losses [Text Block]	Note 3. The allowance for credit losses on trade receivables was approximately $122 and $50 on gross trade receivables of $9,467 and $7,952 as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023

Note 4 - Inventories, Net

Note 4 - Inventories, Net	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	Note 4. Inventories, which are presented net of allowance for slow moving, excess, and obsolete inventory, consisted of the following: September 30, 2024 December 31, 2023 Finished goods $ 3,589 $ 4,622 Work in process 4,117 8,275 Raw materials 10,968 11,055 $ 18,674 $ 23,952 Allowances for slow-moving, excess, or obsolete inventory are used to state the Company’s inventories at the lower of cost or net realizable value. The allowances were approximately $1,354 as of September 30, 2024 December 31, 2023

Note 5 - Income Taxes

Note 5 - Income Taxes	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 5. The Company has recorded $247 and $488 tax expense for the three nine September 30, 2024 no The Company’s income tax provision is based on management’s estimate of the effective tax rate for the full year. The tax provision (benefit) in any period will be affected by, among other things, permanent, as well as temporary, differences in the deductibility of certain items, changes in the valuation allowance related to net deferred tax assets, in addition to changes in tax legislation. As a result, the Company may As of September 30, 2024 In order to fully utilize the net deferred tax assets, the Company will need to generate sufficient taxable income in future years. The Company analyzed all positive and negative evidence to determine if, based on the weight of available evidence, it is more likely than not Based on the analysis of all available evidence, both positive and negative, the Company has concluded that it does not September 30, 2024, December 31, 2023, may September 30, 2024.

Note 6 - Capitalized Product De

Note 6 - Capitalized Product Development Costs	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Capitalized Product Development Costs Disclosure [Text Block]	Note 6. The Company accounts for the costs of Land Mobile Radio (LMR) multi-band development within its products in accordance with ASC Topic 350 30, Intangibles Goodwill and Other, 9000 June 2023, 350 30. not ten three nine September 30, 2024

Note 7 - Investments

Note 7 - Investments	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Investment [Text Block]	Note 7. On January 25, 2024, first 2024. The investment in the Series B common membership interests of FG Holdings LLC was measured using the NAV practical expedient in accordance with ASC 820 not eight no not not As of December 31, 2023 December 14, 2023,

Note 8 - Stockholders' Equity

Note 8 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Equity [Text Block]	Note 8. Stockholders Equity Effective on April 21, 2023, 1 10 The changes in condensed consolidated stockholders’ equity for the three nine September 30, 2024 2023 Common Common Additional Stock Stock Paid-In Accumulated Treasury Shares Amount Capital Deficit Stock Total Balance at December 31, 2023 3,867,082 $ 2,320 $ 48,602 $ (24,209 ) $ (5,402 ) $ 21,311 Common stock issued under restricted stock units 4,710 3 (3 ) — — — Share-based compensation expense-stock options — — 55 — — 55 Share-based compensation expense-restricted stock units — — 121 — — 121 Treasury shares — — — — (651 ) (651 ) Net income — — — 681 — 681 Balance at March 31, 2024 3,871,792 2,323 48,775 (23,528 ) (6,053 ) 21,517 Common stock issued under restricted stock units 6,006 4 (4 ) — — — Share-based compensation expense-stock options — — 77 — — 77 Share-based compensation expense-restricted stock units — — 148 — — 148 Net income — — — 1,664 — 1,664 Balance at June 30, 2024 3,877,798 2,327 48,996 (21,864 ) (6,053 ) 23,406 Common stock issued under restricted stock units 21,327 12 (12 ) — — — Common stock issued - exercised warrants 6,018 4 (4 ) — — — Share-based compensation expense-stock options — — 78 — — 78 Share-based compensation expense-restricted stock units — — 146 — — 146 Net income — — — 2,357 — 2,357 Balance at September 30, 2024 3,905,143 $ 2,343 $ 49,204 $ (19,507 ) $ (6,053 ) $ 25,987 Common Common Additional Stock Stock Paid-In Accumulated Treasury Shares Amount Capital Deficit Stock Total Balance at December 31, 2022 3,686,939 $ 2,212 $ 45,304 $ (21,979 ) $ (5,402 ) $ 20,135 Common stock issued 858 1 14 — — 15 Common stock issued under restricted stock units 1,920 1 (1 ) — — — Share-based compensation expense-stock options — — 58 — — 58 Share-based compensation expense-restricted stock units — — 69 — — 69 Net loss — — — (1,270 ) — (1,270 ) Balance at March 31, 2023 3,689,717 2,214 45,444 (23,249 ) (5,402 ) 19,007 Common stock issued 2,661 2 33 — — 35 Common stock issued under restricted stock units 1,920 1 (1 ) — — — Share-based compensation expense-stock options — — 61 — — 61 Share-based compensation expense-restricted stock units — — 63 — — 63 Net loss — — — (1,340 ) — (1,340 ) Balance at June 30, 2023 3,694,298 2,217 45,600 (24,589 ) (5,402 ) 17,826 Common stock issued 1,254 1 12 — — 13 Common stock issued under restricted stock units 27,418 16 (16 ) — — — Share-based compensation expense-stock options — — 44 — — 44 Share-based compensation expense-restricted stock units — — 641 — — 641 Net loss — — — 90 — 90 Balance at September 30, 2023 3,722,970 $ 2,234 $ 46,281 $ (24,499 ) $ (5,402 ) $ 18,614

Note 9 - Income (Loss) Per Shar

Note 9 - Income (Loss) Per Share	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 9. The following table sets forth the computation of basic and diluted income (loss) per share: Three Months Ended Nine Months Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Numerator: Net income (loss) for basic and diluted earnings per share $ 2,357 $ 90 $ 4,702 $ (2,520 ) Denominator for basic income (loss) per share weighted average shares 3,539,841 3,411,813 3,536,100 3,404,395 Effect of dilutive securities: Options, restricted stock units, and warrants 211,232 33,209 87,141 — Denominator for diluted income (loss) per share weighted average shares 3,751,073 3,445,022 3,623,241 3,404,395 Basic income (loss) per share $ 0.67 $ 0.03 $ 1.33 $ (0.74 ) Diluted income (loss) per share $ 0.63 $ 0.03 $ 1.30 $ (0.74 ) Approximately 21,700 stock options and 20,435 restricted stock units for the three nine September 30, 2024, three nine September 30, 2023,

Note 10 - Non-cash Share-based

Note 10 - Non-cash Share-based Employee Compensation	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	Note 10. Stock Options The Company has employee and non-employee director share-based incentive compensation plans. Related to these programs, the Company recorded non-cash share-based employee compensation expense of $78 and $210 for the three nine September 30, 2024 no The Company uses the Black-Scholes-Merton option valuation model to calculate the fair value of stock option grants under this plan. The non-cash share-based employee compensation expense recorded in the three nine September 30, 2024 10 10 December 31, 2023 A summary of activity under the Company’s stock option plans during the nine September 30, 2024 Wgt. Avg. Wgt. Avg. Wgt. Avg. Exercise Remaining Grant Date Aggregate Stock Price ($) Contractual Fair Value Intrinsic As of January 1, 2024 Options Per Share Life (Years) ($) Per Share Value ($) Outstanding 202,600 14.76 7.60 5.94 37,773 Vested 105,313 16.01 6.80 5.78 9,661 Nonvested 97,287 13.41 8.74 6.12 28,112 Period activity Issued 115,900 12.31 — 7.29 — Exercised — — — — — Forfeited 27,200 16.25 — 6.98 — Expired — — — — — As of September 30, 2024 Outstanding 291,300 13.65 7.96 6.38 2,399,704 Vested 114,840 15.11 6.58 5.48 798,417 Nonvested 176,460 1,270 8.86 6.97 1,601,287 Restricted Stock Units The Company recorded non-cash restricted stock unit compensation expense of $146 and $415 for the three nine September 30, 2024 A summary of non-vested restricted stock under the Company’s non-employee director share-based incentive compensation plan is as follows: Weighted Average Number of Grant Date Shares Price per Share Unvested as of January 1, 2024 19,587 $ 13.22 Granted 55,102 11.72 Vested and issued (32,045 ) 11.73 Cancelled/forfeited — — Unvested as of September 30, 2024 42,644 $ 12.39

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 11. Legal Matters From time to time, the Company may may not not not no September 30, 2024 Purchase Commitments As of September 30, 2024 Significant Customers Sales to United States government agencies represented approximately $7,896 (39.1%) and $23,879 (40.7%) of the Company’s net total sales for the three nine September 30, 2024 September 30, 2024 Geopolitical Tensions and COVID- 19 U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the military conflicts between Russia and Ukraine, and in the Middle East. Although the length and impact of the ongoing military conflicts is highly unpredictable, the conflict in both of these regions could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions. While the impacts of COVID- 19 2023 19 19

Note 12 - Debt

Note 12 - Debt	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 12. Credit Facilities On November 22, 2022, November 28, 2022, not one November 2023. September 30, 2024 three nine September 30, 2024 may may The Company used approximately $4.5 million of IPSA funding to repay the outstanding balance of the previous credit facility with JP Morgan Chase Bank, N.A. (“JPMC”), which expired on January 31, 2023. During the three nine September 30, 2024 no three nine September 30, 2024 As of September 30, 2024 October 30, 2024, 14 Notes Payable On April 6, 2021, June 27, 2023. On September 25, 2019, October 25, 2019, September 25, 2024, June 24, 2024.

Note 13 - Leases

Note 13 - Leases	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Lessor, Operating Leases [Text Block]	Note 13. The Company accounts for its leasing arrangements in accordance with Topic 842, As most of its leases do not may The Company leases approximately 54,000 square feet ( not June 30, 2027. five In February 2020, not 1619 136th July 1, 2020. first 12 Lease costs consisted of the following: Three Months Ended Nine Months Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Operating lease cost $ 136 $ 135 $ 406 $ 407 Variable lease cost 33 33 100 99 Total lease cost $ 169 $ 168 $ 506 $ 506 Supplemental cash flow information related to leases was as follows: Three Months Ended Nine Months Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows (fixed payments) $ 155 $ 149 $ 455 $ 445 Operating cash flows (liability reduction) $ 135 $ 123 $ 390 $ 360 ROU assets obtained in exchange for lease obligations: Operating leases $ 4 $ — $ 27 $ — Other information related to operating leases was as follows: September 30, 2024 Weighted average remaining lease term (in years) 2.59 Weighted average discount rate 5.50 % Maturity of lease liabilities as of September 30, 2024 September 30, 2024 Remaining three months of 2024 $ 157 2025 624 2026 486 2027 248 2028 5 Thereafter 3 Total payments 1,523 Less: imputed interest (101 ) Total present value of lease liabilities $ 1,422

Note 14 - Subsequent Events

Note 14 - Subsequent Events	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	14. Subsequent Events On October 30, 2024, one may may 10 BK Technologies, Inc.’s repayment obligations under the credit facility are guaranteed by the Company and RELM Communications, Inc. and secured by a pledge of essentially all of the assets of BK Technologies, Inc., the Company and RELM Communications, Inc. (collectively, the “Loan Parties”). The Loan Parties are subject to customary negative covenants, including with respect to their ability to incur additional indebtedness, encumber and dispose of their assets and enter into affiliate transactions. BK Technologies, Inc. must also comply with a maximum total funded debt ratio of 2.00 to 1.00 1.00,

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
	Sep. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	OTHER
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The condensed consolidated balance sheet as of September 30, 2024 three nine September 30, 2024 2023 nine September 30, 2024 2023 December 31, 2023 These condensed consolidated financial statements have been prepared in accordance with the requirements of Article 8 X 10 10 December 31, 2023 March 14, 2024. three nine September 30, 2024 2023 not
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accounts of the Company and its subsidiaries have been included in the accompanying condensed consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates entities in which it has a controlling financial interest. When the Company does not 20% 50% not
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, trade accounts receivable, investments, accounts payable, accrued expenses, notes payable, credit facilities, and other liabilities. As of September 30, 2024 December 31, 2023 Effective September 14, 2022, 7, 820 not not On January 25, 2024, first 2024.
Liquidity [Policy Text Block]	Liquidity On November 22, 2022, one November 22, 2023, one 12 September 2024. October 30, 2024, 14 Management believes that cash and cash equivalents currently available, combined with anticipated cash to be generated from operations, and borrowing ability are sufficient to meet the Company’s working capital requirements in the foreseeable future. The Company generally relies on cash from operations, commercial debt, and equity offerings to the extent available, to satisfy its liquidity needs and to meet its payment obligations. The Company may
Stockholders' Equity, Policy [Policy Text Block]	Reverse Stock Split On March 23, 2023, one 1 five 5 April 4, 2023, The Company executed the Reverse Stock Split, which became effective at 5:00 April 21, 2023.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements The Company does not not In November 2023, 2023 07 280 December 15, 2023, December 15, 2024.

Note 4 - Inventories, Net (Tabl

Note 4 - Inventories, Net (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, 2024 December 31, 2023 Finished goods $ 3,589 $ 4,622 Work in process 4,117 8,275 Raw materials 10,968 11,055 $ 18,674 $ 23,952

Note 8 - Stockholders' Equity (

Note 8 - Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Stockholders Equity [Table Text Block]	Common Common Additional Stock Stock Paid-In Accumulated Treasury Shares Amount Capital Deficit Stock Total Balance at December 31, 2023 3,867,082 $ 2,320 $ 48,602 $ (24,209 ) $ (5,402 ) $ 21,311 Common stock issued under restricted stock units 4,710 3 (3 ) — — — Share-based compensation expense-stock options — — 55 — — 55 Share-based compensation expense-restricted stock units — — 121 — — 121 Treasury shares — — — — (651 ) (651 ) Net income — — — 681 — 681 Balance at March 31, 2024 3,871,792 2,323 48,775 (23,528 ) (6,053 ) 21,517 Common stock issued under restricted stock units 6,006 4 (4 ) — — — Share-based compensation expense-stock options — — 77 — — 77 Share-based compensation expense-restricted stock units — — 148 — — 148 Net income — — — 1,664 — 1,664 Balance at June 30, 2024 3,877,798 2,327 48,996 (21,864 ) (6,053 ) 23,406 Common stock issued under restricted stock units 21,327 12 (12 ) — — — Common stock issued - exercised warrants 6,018 4 (4 ) — — — Share-based compensation expense-stock options — — 78 — — 78 Share-based compensation expense-restricted stock units — — 146 — — 146 Net income — — — 2,357 — 2,357 Balance at September 30, 2024 3,905,143 $ 2,343 $ 49,204 $ (19,507 ) $ (6,053 ) $ 25,987 Common Common Additional Stock Stock Paid-In Accumulated Treasury Shares Amount Capital Deficit Stock Total Balance at December 31, 2022 3,686,939 $ 2,212 $ 45,304 $ (21,979 ) $ (5,402 ) $ 20,135 Common stock issued 858 1 14 — — 15 Common stock issued under restricted stock units 1,920 1 (1 ) — — — Share-based compensation expense-stock options — — 58 — — 58 Share-based compensation expense-restricted stock units — — 69 — — 69 Net loss — — — (1,270 ) — (1,270 ) Balance at March 31, 2023 3,689,717 2,214 45,444 (23,249 ) (5,402 ) 19,007 Common stock issued 2,661 2 33 — — 35 Common stock issued under restricted stock units 1,920 1 (1 ) — — — Share-based compensation expense-stock options — — 61 — — 61 Share-based compensation expense-restricted stock units — — 63 — — 63 Net loss — — — (1,340 ) — (1,340 ) Balance at June 30, 2023 3,694,298 2,217 45,600 (24,589 ) (5,402 ) 17,826 Common stock issued 1,254 1 12 — — 13 Common stock issued under restricted stock units 27,418 16 (16 ) — — — Share-based compensation expense-stock options — — 44 — — 44 Share-based compensation expense-restricted stock units — — 641 — — 641 Net loss — — — 90 — 90 Balance at September 30, 2023 3,722,970 $ 2,234 $ 46,281 $ (24,499 ) $ (5,402 ) $ 18,614

Note 9 - Income (Loss) Per Sh_2

Note 9 - Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Nine Months Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Numerator: Net income (loss) for basic and diluted earnings per share $ 2,357 $ 90 $ 4,702 $ (2,520 ) Denominator for basic income (loss) per share weighted average shares 3,539,841 3,411,813 3,536,100 3,404,395 Effect of dilutive securities: Options, restricted stock units, and warrants 211,232 33,209 87,141 — Denominator for diluted income (loss) per share weighted average shares 3,751,073 3,445,022 3,623,241 3,404,395 Basic income (loss) per share $ 0.67 $ 0.03 $ 1.33 $ (0.74 ) Diluted income (loss) per share $ 0.63 $ 0.03 $ 1.30 $ (0.74 )

Note 10 - Non-cash Share-base_2

Note 10 - Non-cash Share-based Employee Compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Wgt. Avg. Wgt. Avg. Wgt. Avg. Exercise Remaining Grant Date Aggregate Stock Price ($) Contractual Fair Value Intrinsic As of January 1, 2024 Options Per Share Life (Years) ($) Per Share Value ($) Outstanding 202,600 14.76 7.60 5.94 37,773 Vested 105,313 16.01 6.80 5.78 9,661 Nonvested 97,287 13.41 8.74 6.12 28,112 Period activity Issued 115,900 12.31 — 7.29 — Exercised — — — — — Forfeited 27,200 16.25 — 6.98 — Expired — — — — — As of September 30, 2024 Outstanding 291,300 13.65 7.96 6.38 2,399,704 Vested 114,840 15.11 6.58 5.48 798,417 Nonvested 176,460 1,270 8.86 6.97 1,601,287
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Weighted Average Number of Grant Date Shares Price per Share Unvested as of January 1, 2024 19,587 $ 13.22 Granted 55,102 11.72 Vested and issued (32,045 ) 11.73 Cancelled/forfeited — — Unvested as of September 30, 2024 42,644 $ 12.39

Note 13 - Leases (Tables)

Note 13 - Leases (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended Nine Months Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Operating lease cost $ 136 $ 135 $ 406 $ 407 Variable lease cost 33 33 100 99 Total lease cost $ 169 $ 168 $ 506 $ 506 September 30, 2024 Weighted average remaining lease term (in years) 2.59 Weighted average discount rate 5.50 %
Lessee, Operating Lease, Supplemental Cash Flow Information [Table Text Block]	Three Months Ended Nine Months Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows (fixed payments) $ 155 $ 149 $ 455 $ 445 Operating cash flows (liability reduction) $ 135 $ 123 $ 390 $ 360 ROU assets obtained in exchange for lease obligations: Operating leases $ 4 $ — $ 27 $ —
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	September 30, 2024 Remaining three months of 2024 $ 157 2025 624 2026 486 2027 248 2028 5 Thereafter 3 Total payments 1,523 Less: imputed interest (101 ) Total present value of lease liabilities $ 1,422

Note 1 - Condensed Consolidat_2

Note 1 - Condensed Consolidated Financial Statements (Details Textual) $ / shares in Units, $ in Thousands					3 Months Ended
	Jan. 25, 2024 USD ($) shares	Nov. 22, 2023	Mar. 23, 2023 $ / shares	Nov. 22, 2022 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2024 $ / shares shares	Dec. 31, 2023 $ / shares shares
Treasury Stock, Shares, Acquired (in shares) | shares	52,000
Treasury Stock, Value, Acquired, Cost Method	$ 650				$ 651
Treasury Stock, Common, Shares (in shares) | shares	342,080					342,080	290,080
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares			$ 0.6			$ 0.6	$ 0.6
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio			5
Alterna Capital Solutions, LLC [Member] | Invoice Purchase and Security Agreement [Member]
Line of Credit Facility, Expiration Period (Year)		1 year		1 year
Line of Credit Facility, Maximum Borrowing Capacity				$ 15,000
FG Holdings LLC. [Member]
Realized Investment Gains (Losses)	$ (91)

Note 2 - Significant Events a_2

Note 2 - Significant Events and Transactions (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Nov. 06, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Stock Issued During Period, Shares, New Issues (in shares)		1,254
Stock Issued During Period, Value, New Issues		$ 13	$ 35	$ 15
East West Warrants [Member]
Warrants and Rights Outstanding, Term (Year)	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	135,300
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 15
Proceeds from Issuance of Warrants, Gross	$ 1,000
Proceeds from Issuance of Warrants, Reduction From Extinguishment of Accounts Payable	950
Proceeds from Issuance of Warrants, Reduction for Obsolete Inventory	$ 50
Stock Purchase Agreement With East West Manufacturing, LLC [Member]
Stock Issued During Period, Shares, New Issues (in shares)	77,520
Stock Issued During Period, Value, New Issues	$ 1,000
Shares Issued, Price Per Share (in dollars per share)	$ 12.9

Note 3 - Allowance for Credit_2

Note 3 - Allowance for Credit Losses (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss, Current	$ 122	$ 50
Accounts Receivable, before Allowance for Credit Loss, Current	$ 9,467	$ 7,952

Note 4 - Inventories, Net (Deta

Note 4 - Inventories, Net (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Inventory Valuation Reserves	$ 1,354	$ 1,838

Note 4 - Inventories, Net - Sch

Note 4 - Inventories, Net - Schedule of Current Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Finished goods	$ 3,589	$ 4,622
Work in process	4,117	8,275
Raw materials	10,968	11,055
Inventory, Net	$ 18,674	$ 23,952

Note 5 - Income Taxes (Details

Note 5 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Income Tax Expense (Benefit)	$ 247	$ 0	$ 488	$ 0
Deferred Income Tax Assets, Net	4,116		4,116		$ 4,116
Deferred Tax Assets, Valuation Allowance	$ 4,365		$ 4,365		$ 4,398

Note 6 - Capitalized Product _2

Note 6 - Capitalized Product Development Costs (Details Textual) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)
Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Capitalized Cost	$ 321	$ 751
In Process Research and Development [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	10 years	10 years

Note 7 - Investments (Details T

Note 7 - Investments (Details Textual) - USD ($) $ in Thousands		3 Months Ended
	Jan. 25, 2024	Mar. 31, 2024	Sep. 30, 2024	Dec. 31, 2023
Treasury Stock, Shares, Acquired (in shares)	52,000
Treasury Stock, Value, Acquired, Cost Method	$ 650	$ 651
Treasury Stock, Common, Shares (in shares)	342,080		342,080	290,080
Series A Preferred Stock [Member] | FG Holdings LLC. [Member]
Preferred Stock, Dividend Rate, Percentage	8%
Preferred Stock, Total Return, Percentage of Positive Profits	20%
Series B Preferred Stock [Member] | FG Holdings LLC. [Member]
Stock Issued During Period, Periodic Return on Investment, Percentage	1.5
FG Holdings LLC. [Member]
Realized Investment Gains (Losses)	$ (91)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments			$ 0
Investment Owned, Balance, Shares (in shares)				5,666,111
Equity Method Investment, Ownership Percentage				55%

Note 8 - Stockholder's Equity -

Note 8 - Stockholder's Equity - Schedule of Stockholder's Equity (Details) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
	Jan. 25, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Balance		$ 23,406	$ 21,517	$ 21,311	$ 17,826	$ 19,007	$ 20,135	$ 21,311	$ 20,135
Common stock issued under restricted stock units (in shares)					27,418
Common stock issued under restricted stock units		0			$ 0
Share-based compensation expense-stock options		78	77	55	44	61	58
Share-based compensation expense-restricted stock units		146	148	121	641	63	69
Treasury shares	$ (650)			(651)
Net income (loss)		2,357	1,664	681	$ 90	(1,340)	(1,270)	4,702	$ (2,520)
Common stock issued - exercised warrants		0
Balance (in shares)					3,722,970				3,722,970
Balance		$ 25,987	23,406	21,517	$ 18,614	17,826	19,007	$ 25,987	$ 18,614
Common stock issued (in shares)					1,254
Common stock issued					$ 13	35	15
Restricted Stock Units (RSUs) [Member]
Common stock issued under restricted stock units			$ 0	$ 0		$ 0	$ 0
Common Stock [Member]
Balance (in shares)		3,877,798	3,871,792	3,867,082	3,694,298	3,689,717	3,686,939	3,867,082	3,686,939
Balance		$ 2,327	$ 2,323	$ 2,320	$ 2,217	$ 2,214	$ 2,212	$ 2,320	$ 2,212
Common stock issued under restricted stock units (in shares)		21,327
Common stock issued under restricted stock units		$ 12			16
Share-based compensation expense-stock options		0	0	0	0	0	0
Share-based compensation expense-restricted stock units		0	0	0	0	0	0
Net income (loss)		$ 0	$ 0	$ 0	0	$ 0	$ 0
Common stock issued - exercised warrants (in shares)		6,018
Common stock issued - exercised warrants		$ 4
Balance (in shares)		3,905,143	3,877,798	3,871,792		3,694,298	3,689,717	3,905,143
Balance		$ 2,343	$ 2,327	$ 2,323	2,234	$ 2,217	$ 2,214	$ 2,343	2,234
Common stock issued (in shares)						2,661	858
Common stock issued					1	$ 2	$ 1
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]
Common stock issued under restricted stock units (in shares)			6,006	4,710		1,920	1,920
Common stock issued under restricted stock units			$ 4	$ 3		$ 1	$ 1
Additional Paid-in Capital [Member]
Balance		48,996	48,775	48,602	45,600	45,444	45,304	48,602	45,304
Common stock issued under restricted stock units		(12)			(16)
Share-based compensation expense-stock options		78	77	55	44	61	58
Share-based compensation expense-restricted stock units		146	148	121	641	63	69
Treasury shares				0
Net income (loss)		0	0	0	0	0	0
Common stock issued - exercised warrants		(4)
Balance		49,204	48,996	48,775	46,281	45,600	45,444	49,204	46,281
Common stock issued					12	33	14
Additional Paid-in Capital [Member] | Restricted Stock Units (RSUs) [Member]
Common stock issued under restricted stock units			(4)	(3)		(1)	(1)
Retained Earnings [Member]
Balance		(21,864)	(23,528)	(24,209)	(24,589)	(23,249)	(21,979)	(24,209)	(21,979)
Common stock issued under restricted stock units		0			0
Share-based compensation expense-stock options		0	0	0	0	0	0
Share-based compensation expense-restricted stock units		0	0	0	0	0	0
Treasury shares				0
Net income (loss)		2,357	1,664	681	90	(1,340)	(1,270)
Common stock issued - exercised warrants		0
Balance		(19,507)	(21,864)	(23,528)	(24,499)	(24,589)	(23,249)	(19,507)	(24,499)
Common stock issued					0	0	0
Retained Earnings [Member] | Restricted Stock Units (RSUs) [Member]
Common stock issued under restricted stock units			0	0		0	0
Treasury Stock, Common [Member]
Balance		(6,053)	(6,053)	(5,402)	(5,402)	(5,402)	(5,402)	(5,402)	(5,402)
Common stock issued under restricted stock units		0			0
Share-based compensation expense-stock options		0	0	0	0	0	0
Share-based compensation expense-restricted stock units		0	0	0	0	0	0
Treasury shares				(651)
Net income (loss)		0	0	0	0	0	0
Common stock issued - exercised warrants		0
Balance		$ (6,053)	(6,053)	(6,053)	(5,402)	(5,402)	(5,402)	$ (6,053)	$ (5,402)
Common stock issued					$ 0	0	0
Treasury Stock, Common [Member] | Restricted Stock Units (RSUs) [Member]
Common stock issued under restricted stock units			$ 0	$ 0		$ 0	$ 0

Note 9 - Income (Loss) Per Sh_3

Note 9 - Income (Loss) Per Share (Details Textual) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2023
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	21,700	168,600	224,600
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	20,435	28,569	29,381

Note 9 - Income (Loss) Per Sh_4

Note 9 - Income (Loss) Per Share - Schedule Of Computation Of Basic And Diluted Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Net income (loss) for basic and diluted earnings per share	$ 2,357	$ 1,664	$ 681	$ 90	$ (1,340)	$ (1,270)	$ 4,702	$ (2,520)
Denominator for basic income (loss) per share weighted average shares (in shares)	3,539,841			3,411,813			3,536,100	3,404,395
Options, restricted stock units, and warrants (in shares)	211,232			33,209			87,141	0
Denominator for diluted income (loss) per share weighted average shares (in shares)	3,751,073			3,445,022			3,623,241	3,404,395
Basic income (loss) per share (in dollars per share)	$ 0.67			$ 0.03			$ 1.33	$ (0.74)
Diluted income (loss) per share (in dollars per share)	$ 0.63			$ 0.03			$ 1.3	$ (0.74)

Note 10 - Non-cash Share-base_3

Note 10 - Non-cash Share-based Employee Compensation (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense	$ 146	$ 641	$ 415	$ 773
Employee And Nonemployee Director [Member] | Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense	78	44	210	163
Share-Based Payment Arrangement, Amount Capitalized	$ 0	$ 0	$ 0	$ 0

Note 10 - Non-Cash Share-Base_4

Note 10 - Non-Cash Share-Based Employee Compensation - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Outstanding, Stock Options (in shares)	202,600
Outstanding, Weighted Average Exercise Price per Share (in dollars per share)	$ 14.76
Outstanding, Weighted Average Remaining Contractual Life (Year)	7 years 11 months 15 days	7 years 7 months 6 days
Outstanding, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 5.94
Outstanding, Aggregate Intrinsic Value	$ 2,399,704	$ 37,773
Vested, Stock Options (in shares)	105,313
Vested, Weighted Average Exercise Price per Share (in dollars per share)	$ 16.01
Vested, Weighted Average Remaining Contractual Life (Year)	6 years 6 months 29 days	6 years 9 months 18 days
Vested, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 5.78
Vested, Aggregate Intrinsic Value	$ 798,417	$ 9,661
Nonvested, Stock Options (in shares)	97,287
Nonvested, Weighted Average Exercise Price per Share (in dollars per share)	$ 13.41
Nonvested, Weighted Average Remaining Contractual Life (Year)	8 years 10 months 9 days	8 years 8 months 26 days
Nonvested, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 6.12
Nonvested, Aggregate Intrinsic Value	$ 1,601,287	$ 28,112
Issued, Stock Options (in shares)	115,900
Issued, Weighted Average Exercise Price per Share (in dollars per share)	$ 12.31
Issued, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 7.29
Exercised, Stock Options (in shares)	0
Exercised, Weighted Average Exercise Price per Share (in dollars per share)	$ 0
Exercised, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 0
Forfeited, Stock Options (in shares)	27,200
Forfeited, Weighted Average Exercise Price per Share (in dollars per share)	$ 16.25
Forfeited, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 6.98
Expired, Stock Options (in shares)	0
Expired, Weighted Average Exercise Price per Share (in dollars per share)	$ 0
Expired, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 0
Outstanding , Stock Options (in shares)	291,300	202,600
Outstanding, Weighted Average Exercise Price per Share (in dollars per share)	$ 13.65	$ 14.76
Outstanding, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 6.38	$ 5.94
Vested, Stock Options (in shares)	114,840	105,313
Vested, Weighted Average Exercise Price per Share (in dollars per share)	$ 15.11	$ 16.01
Vested, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 5.48	$ 5.78
Nonvested, Stock Options (in shares)	176,460	97,287
Nonvested, Weighted Average Exercise Price per Share (in dollars per share)	$ 1,270	$ 13.41
Nonvested, Weighted Average Grant Date Fair Value per Share (in dollars per share)	$ 6.97	$ 6.12

Note 10 - Non-cash Share-base_5

Note 10 - Non-cash Share-based Employee Compensation - Summary of Non-vested Restricted Stock (Details) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Unvested, Number of Shares (in shares) | shares	19,587
Unvested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 13.22
Granted, Number of Shares (in shares) | shares	55,102
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 11.72
Vested and issued, Number of Shares (in shares) | shares	(32,045)
Vested and issued, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 11.73
Cancelled/forfeited, Number of Shares (in shares) | shares	0
Cancelled/forfeited, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 0
Unvested, Number of Shares (in shares) | shares	42,644
Unvested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 12.39

Note 11 - Commitments and Con_2

Note 11 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue from Contract with Customer, Including Assessed Tax	$ 20,179	$ 20,069	$ 58,664	$ 57,786
United States Government Agencies [Member]
Revenue from Contract with Customer, Including Assessed Tax	7,896	12,142	23,879	29,571
Accounts Receivable, after Allowance for Credit Loss	$ 1,997	$ 4,280	$ 1,997	$ 4,280
United States Government Agencies [Member] | Revenue Benchmark [Member] | Government Contracts Concentration Risk [Member]
Concentration Risk, Percentage	39.10%	60.50%	40.70%	51.20%
Inventories [Member]
Purchase Obligation	$ 7,285		$ 7,285

Note 12 - Debt (Details Textual

Note 12 - Debt (Details Textual) $ in Thousands					3 Months Ended	9 Months Ended
	Nov. 22, 2023	Jan. 01, 2023 USD ($)	Nov. 22, 2022 USD ($)	Sep. 25, 2019 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)	Apr. 06, 2021 USD ($)
Alterna Capital Solutions, LLC [Member] | Accounts Receivable [Member]
Transferred Receivables, Face Value					$ 19,500	$ 54,900
Proceeds from Exchange of Short-Term Trade Receivables					17,400	46,400
Gain/(Loss) on Exchange of Short-Term Trade Receivables					$ 0	$ 0
Alterna Capital Solutions, LLC [Member] | Invoice Purchase and Security Agreement [Member]
Line of Credit Facility, Borrowing Capacity, Percentage of Net Orderly Liquidation Value			75%
Line of Credit Facility, Borrowing Capacity, Maximum Percentage of Eligible Account Balances			100%
Line of Credit Facility, Expiration Period (Year)	1 year		1 year
Line of Credit Facility, Maximum Borrowing Capacity			$ 15,000
Debt Instrument, Interest Rate, Stated Percentage			1.85%
Debt Instrument, Interest Rate, Effective Percentage					10.10%	10.10%
Debt Instrument, Interest Expense and Related Servicing Fees					$ 18	$ 356
Transferred Short-Term Trade Receivable to Cash, Percentage			85%
Long-Term Line of Credit					0	0
Alterna Capital Solutions, LLC [Member] | Invoice Purchase and Security Agreement [Member] | Accounts Receivable [Member]
Secured Borrowings, Gross Including Not Subject to Master Netting Arrangement					$ 7,900	$ 7,900
JP Morgan Chase Bank, N.A. [Member] | Notes Payable to Banks [Member]
Repayments of Lines of Credit		$ 4,500
Debt Instrument, Face Amount							$ 743
U.S. Bank Equipment Finance [Member] | Notes Payable to Banks [Member]
Debt Instrument, Interest Rate, Stated Percentage				5.11%
Debt Instrument, Face Amount				$ 425
Debt Instrument, Number of Payments for Principal and Interest				60
Debt Instrument, Periodic Payment				$ 8

Note 13 - Leases (Details Textu

Note 13 - Leases (Details Textual) $ in Thousands	1 Months Ended	6 Months Ended	9 Months Ended
	Feb. 29, 2020 ft²	Dec. 31, 2020 USD ($)	Sep. 30, 2024 USD ($) ft²
Industrial Space in West Melbourne, Florida [Member]
Area of Real Estate Property (Square Foot) | ft²			54,000
Lessee, Operating Lease, Term of Contract (Year)			5 years
Lessee, Operating Lease, Annual Rental, Maintenance, and Tax Expense | $			$ 491
Office Space at Sawgrass Technology Park [Member]
Area of Real Estate Property (Square Foot) | ft²	6,857
Lessee, Operating Lease, Term of Contract (Year)	64 months
Lessee, Operating Lease, Annual Rental, Maintenance, and Tax Expense | $		$ 196
Lessee, Operating Lease, Annual Percentage Increase in Rental, Maintenance, and Tax Expenses	3%

Note 13 - Leases - Schedule of

Note 13 - Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating lease cost	$ 136	$ 135	$ 406
Total lease cost		$ 169	$ 168	$ 506
Weighted average remaining lease term (in years) (Year)	2 years 7 months 2 days		2 years 7 months 2 days
Weighted average discount rate	5.50%		5.50%

Note 13 - Leases - Schedule o_2

Note 13 - Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating cash flows (fixed payments)	$ 155	$ 149	$ 455	$ 445
Operating cash flows (liability reduction)	135	123	390	360
Operating leases	$ 4	$ 0	$ 27	$ 0

Note 13 - Leases - Schedule o_3

Note 13 - Leases - Schedule of Operating Lease Liabilities Maturity Payments (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Remaining three months of 2024	$ 157
2025	624
2026	486
2027	248
2028	5
Thereafter	3
Total payments	1,523
Less: imputed interest	(101)
Total present value of lease liabilities	$ 1,422

Note 14 - Subsequent Events (De

Note 14 - Subsequent Events (Details Textual) - Revolving Credit Facility [Member] - Fifth Third Credit Agreement [Member] - Subsequent Event [Member] $ in Millions	Oct. 31, 2024 USD ($)
Debt Instrument, Term (Year)	1 year
Line of Credit Facility, Maximum Borrowing Capacity	$ 6
Line of Credit Facility, Maximum Borrowing Capacity, Accordion Feature	4
Line of Credit Facility, Maximum Borrowing Capacity, Including Accordion Feature, Total	$ 10
Debt Instrument, Interest Rate, Stated Percentage	2.50%
Debt Instrument, Covenant, Total Funded Debt Ratio	2
Debt Instrument, Covenant, Fixed Charge Ratio	1.2